Results 181 to 190 of about 3,236 (190)

RIPK1 INHIBITORS AND METHODS OF USE

2021
RICO DUQUE JENNY LORENA, BRILL ZACHARY, FRADERA XAVIER, SILIPHAIVANH PHIENG, SU JING   +4 more
openaire   +1 more source

Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway

Molecular Cell
Daichao Xu, Bing Shan
exaly  

CRYSTALLINE FORMS OF A RIPK1 INHIBITOR

2023
DUAN SHAOMING, SHAW SIMON, WANG XIN
openaire   +1 more source

APPLICATION OF PRIMIDONE AS RIPK1 INHIBITOR

2022
ZHA YUNHONG, HU XINQIAN, HE XIAOYAN, MOU YAN, ZHU GUOFENG, WEI JUN, ZHANG HONGBING, WANG JUN, ZHAO HAILONG, HUANG MING, YU YAJIE, LI MIN, AN DEHAI, WANG JIA, YOU XIAOLING, GU TANRONG, XIAO XIN   +16 more
openaire   +1 more source

The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation

Immunity
Chun Kim, Gianmaria Liccardi, Vangelis Kondylis   +2 more
exaly  

The interaction between RIPK1 and FADD controls perinatal lethality and inflammation

Cell Reports
Douglas Green, Bart Tummers
exaly  

COMPOUNDS USEFUL AS RIPK1 INHIBITORS

2022
ESTRADA ANTHONY A, FENG JIANWEN A, FOX BRIAN, HU CHENG, OSIPOV MAKSIM, SWEENEY ZACHARY K, DE VICENTE FIDALGO JAVIER, THOTTUMKARA ARUN   +7 more
openaire   +1 more source

RIPK1 INHIBITORS AND METHODS OF USE

2023
CHEN JOANNA L, CHEN YI-HENG, DIMAURO ERIN F, LU MIN, METHOT JOEY L, MUSACCHIO ANDREW J, PALANI ANANDAN, PIO BARBARA, RICO DUQUE LORENA, SILIPHAIVANH PHIENG, VARA BRANDON A   +10 more
openaire   +1 more source

HETEROCYCLIC COMPOUND AS RIPK1 INHIBITOR

KONG NORMAN XIANGLONG, ZHOU CHAO
openaire   +1 more source

RIPK1 INHIBITORS AND METHODS OF USE

ACHAB ABDELGHANI ABE, BOYKO YAROSLAV, CHEN YI-HENG, DIMAURO ERIN F, RICO DUQUE JENNY LORENA, FRADERA XAVIER, PALANI ANANDAN, PIO BARBARA, RICKARD MEREDITH M, SILIPHAIVANH PHIENG, SU JING, VARA BRANDON A   +11 more
openaire   +1 more source